As a C5aR antagonist, avacopan prevented the development of glomerulonephritis induced by anti-myeloperoxidase antibodies in a murine model of ANCA-associated vasculitis [22]. Here, MPO is linked to anti-neutrophil cytoplasmic antibody-associated vasculitis.